Rare diseases
Investigational molecules
Locations
100 Morris Street, 07960-4563, United States
Principia Biopharma Inc. focuses its clinical research activity on immune thrombocytopenia (ITP), with studies in adult and adolescent populations affected by persistent, chronic, relapsed, or refractory disease. Its research portfolio is centered on improving platelet response and sustaining clinical benefit in patients with limited response to prior therapies.
The sponsor’s clinical activity is concentrated in the evaluation of treatment options for immune-mediated bleeding disorders, with interest in response durability and disease control across multiple patient groups.
Principia Biopharma Inc. runs clinical trials in conditions such as Immune thrombocytopenia, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Bulgaria
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
